Schimmel Paul (CIK 0001236447)

Latest company ownership

ATYR - aTYR PHARMA INC
Role: Director
Shares held
688,033
Last filed at
Oct 9, 2025
Confidence Score
85.7
2025Q4
Confidence Score History
2016Q2 2025Q4
Shares held
306,996
Last filed at
Dec 22, 2015
Confidence Score
50.0
2025Q4
Confidence Score History
2013Q4 2025Q4
Shares held
7,500
Last filed at
Oct 4, 2019
Confidence Score
50.0
2025Q4
Confidence Score History
2017Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Oct 8, 2025 Oct 9, 2025 aTYR PHARMA INC Director Buy 97.5 +1,000,000 237.02% ✗ $911.8K
Jul 22, 2024 Jul 24, 2024 aTYR PHARMA INC Director Buy 95.0 +100,000 31.06% ✗ $184.6K
May 10, 2023 May 11, 2023 aTYR PHARMA INC Director Buy 97.5 +200,000 164.05% ✗ $450K
Sep 20, 2021 Sep 22, 2021 aTYR PHARMA INC Director Buy 100.0 +250,000 57.87% ✗ $2M
May 18, 2021 May 20, 2021 aTYR PHARMA INC Director Buy 95.0 +50,000 75.86% ✗ $199K
May 20, 2020 May 22, 2020 aTYR PHARMA INC Director Sell 26.3 -8,447 -1.92% ✗ $30.7K
Feb 10, 2020 Feb 11, 2020 aTYR PHARMA INC Director Buy 100.0 +254,000 136.21% ✗ $1.1M
Nov 26, 2018 Nov 28, 2018 aTYR PHARMA INC Director Buy 95.0 +147,225 18.98% ✗ $79.8K
Aug 31, 2018 Sep 5, 2018 aTYR PHARMA INC Director Buy 86.3 +42,749 5.83% ✗ $31.5K
Aug 29, 2018 Aug 31, 2018 aTYR PHARMA INC Director Buy 95.0 +164,411 28.93% ✗ $121.6K
May 18, 2018 May 21, 2018 aTYR PHARMA INC Director Buy 95.0 +150,000 35.85% ✗ $149.4K
Mar 13, 2018 Mar 14, 2018 ALNYLAM PHARMACEUTICALS, INC. Director Sell 23.8 -27,823 -8.31% ✓ $4.2M
Aug 31, 2017 Sep 5, 2017 aTYR PHARMA INC Director Buy 95.0 +94,336 29.11% ✗ $250K
Apr 19, 2017 Apr 21, 2017 Forte Biosciences, Inc. Director Buy 95.0 +10,000 276.01% ✗ $100K
Dec 20, 2016 Dec 22, 2016 aTYR PHARMA INC Director Buy 87.5 +25,000 3.39% ✗ $56.9K
Sep 23, 2016 Dec 19, 2016 aTYR PHARMA INC Director Buy 90.0 +50,000 7.28% ✗ $123.9K
Apr 14, 2016 Apr 15, 2016 aTYR PHARMA INC Director Buy 97.5 +66,219 24.49% ✗ $276.9K
Apr 13, 2016 Apr 14, 2016 aTYR PHARMA INC Director Buy 83.8 +9,835 3.77% ✗ $37.9K
Apr 12, 2016 Apr 13, 2016 aTYR PHARMA INC Director Buy 83.8 +9,127 3.63% ✗ $33.9K
Apr 11, 2016 Apr 13, 2016 aTYR PHARMA INC Director Buy 95.0 +32,659 14.93% ✗ $116.5K
Apr 11, 2016 Apr 12, 2016 aTYR PHARMA INC Director Buy 87.5 +32,659 3.83% ✗ $116.5K
Apr 8, 2016 Apr 11, 2016 aTYR PHARMA INC Director Buy 97.5 +85,000 11.07% ✗ $273.6K
Apr 7, 2016 Apr 8, 2016 aTYR PHARMA INC Director Buy 90.0 +40,000 5.49% ✗ $127.6K
Apr 6, 2016 Apr 7, 2016 aTYR PHARMA INC Director Buy 87.5 +25,000 3.56% ✗ $80K
Apr 5, 2016 Apr 6, 2016 aTYR PHARMA INC Director Buy 87.5 +25,000 3.69% ✗ $88.1K
Apr 21, 2015 Apr 23, 2015 ALNYLAM PHARMACEUTICALS, INC. Director Sell 32.5 -10,000 -3.12% ✓ $1.3M
Mar 17, 2015 Mar 19, 2015 ALNYLAM PHARMACEUTICALS, INC. Director Sell 32.5 -10,000 -3.12% ✓ $1.2M
Dec 8, 2014 Dec 10, 2014 ALNYLAM PHARMACEUTICALS, INC. Director Sell 32.5 -15,000 -4.60% ✓ $1.6M
Oct 28, 2014 Oct 30, 2014 ALNYLAM PHARMACEUTICALS, INC. Director Sell 32.5 -15,000 -4.60% ✓ $1.4M
Jan 13, 2014 Jan 14, 2014 ALNYLAM PHARMACEUTICALS, INC. Director Sell 32.5 -15,000 -4.60% ✓ $1.3M
Dec 20, 2013 Dec 23, 2013 ALNYLAM PHARMACEUTICALS, INC. Director Sell 35.0 -15,000 -4.55% ✓ $975K
Oct 22, 2013 Oct 24, 2013 ALNYLAM PHARMACEUTICALS, INC. Director Sell 35.0 -15,000 -4.55% ✓ $900K